ConductScience.org, home

Paper33949293

Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma.

Huang HQ and 9 others. Bioengineered, 2021. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma. Papers, record 33949293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33949293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma.
PubMed
Journal
Bioengineered
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2022-02-04
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang HQHe-Qing
2Chen GGang
3Xiong DDDan-Dan
4Lai ZFZe-Feng
5Liu LMLi-Min
6Fang YYYe-Ying
7Shen JHJin-Hai
8Gan XYXiang-Yu
9Liao LFLiu-Feng
10Dang YWYi-Wu

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Down-RegulationMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Liver NeoplasmsMajor topic
MicroRNAsMajor topic
Female
Gene Expression Profiling
Humans
Male
Prognosis
ROC Curve
Risk Factors

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131934299Exploration and validation of downregulated microRNA-199a-3p, downstream messenger RNA targets and transcriptional regulation in osteosarcoma.Am J Transl Res2019https://conductscience.org/library/papers/31934299PubMed
231612005HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma.Oncol Lett2019https://conductscience.org/library/papers/31612005PubMed
325613900Proteomics. Tissue-based map of the human proteome.Science2015https://conductscience.org/library/papers/25613900PubMed
431730902LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma.Cancer Lett2020https://conductscience.org/library/papers/31730902PubMed
532366840Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.Cell Death Dis2020https://conductscience.org/library/papers/32366840PubMed
631814271Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis.Small2020https://conductscience.org/library/papers/31814271PubMed
733188512Current perspectives on the tumor microenvironment in hepatocellular carcinoma.Hepatol Int2020https://conductscience.org/library/papers/33188512PubMed
831934297Identifying TF-miRNA-mRNA regulatory modules in nitidine chloride treated HCC xenograft of nude mice.Am J Transl Res2019https://conductscience.org/library/papers/31934297PubMed
933433946Cancer Statistics, 2021.CA Cancer J Clin2021https://conductscience.org/library/papers/33433946PubMed
1026808342Cancer statistics in China, 2015.CA Cancer J Clin2016https://conductscience.org/library/papers/26808342PubMed
1130718452miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.Cell Death Dis2019https://conductscience.org/library/papers/30718452PubMed
1230364632Coordinative control of G2/M phase of the cell cycle by non-coding RNAs in hepatocellular carcinoma.PeerJ2018https://conductscience.org/library/papers/30364632PubMed
1331168049Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma.Cell Death Dis2019https://conductscience.org/library/papers/31168049PubMed
1430007991Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases.Med Sci Monit2018https://conductscience.org/library/papers/30007991PubMed
1531819482MIR22HG As A Tumor Suppressive lncRNA In HCC: A Comprehensive Analysis Integrating RT-qPCR, mRNA-Seq, And Microarrays.Onco Targets Ther2019https://conductscience.org/library/papers/31819482PubMed
1631281357A Comprehensive Evaluation of the Association between Polymorphisms in XRCC1, ERCC2, and XRCC3 and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis.J Oncol2019https://conductscience.org/library/papers/31281357PubMed
1728402280Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma.Oncotarget2017https://conductscience.org/library/papers/28402280PubMed
1830832674Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.Respir Res2019https://conductscience.org/library/papers/30832674PubMed
1926226356miRWalk2.0: a comprehensive atlas of microRNA-target interactions.Nat Methods2015https://conductscience.org/library/papers/26226356PubMed
2032931665The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.Cancer Med2020https://conductscience.org/library/papers/32931665PubMed

See all 47 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42326330Alkaloids mediated regulation of microRNA in cancer: molecular insights and emerging therapeutic strategies.Front Oncol2026https://conductscience.org/library/papers/42326330PubMed
40626007Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p.Front Oncol2025https://conductscience.org/library/papers/40626007PubMed
39764737The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO.Cancer Rep (Hoboken)2025https://conductscience.org/library/papers/39764737PubMed
38976685The expression of MIR125B transcripts and bone phenotypes in Mir125b2-deficient mice.PLoS One2024https://conductscience.org/library/papers/38976685PubMed
38139235Plasma microRNA Profiling in Type 2 Diabetes Mellitus: A Pilot Study.Int J Mol Sci2023https://conductscience.org/library/papers/38139235PubMed
36914902Nitidine chloride regulates cell function of bladder cancer in vitro through downregulating Lymphocyte antigen 75.Naunyn Schmiedebergs Arch Pharmacol2023https://conductscience.org/library/papers/36914902PubMed
36118845The diagnostic and prognostic value of the miR-17-92 cluster in hepatocellular carcinoma: A meta-analysis.Front Genet2022https://conductscience.org/library/papers/36118845PubMed
35628654The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines.Int J Mol Sci2022https://conductscience.org/library/papers/35628654PubMed
35443866MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7.Bioengineered2022https://conductscience.org/library/papers/35443866PubMed
34608826Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.Bioengineered2021https://conductscience.org/library/papers/34608826PubMed
34516334MicroRNA miR-495 regulates the development of Hepatocellular Carcinoma by targeting C1q/tumor necrosis factor-related protein-3 (CTRP3).Bioengineered2021https://conductscience.org/library/papers/34516334PubMed
34346845Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p.Bioengineered2021https://conductscience.org/library/papers/34346845PubMed
34180758Upregulation of microRNA miR-141-3p and its prospective targets in endometrial carcinoma: a comprehensive study.Bioengineered2021https://conductscience.org/library/papers/34180758PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DNAJB13337PubTator's text mininghttps://conductscience.org/library/genes/3337NCBI Gene
ELAVL21993PubTator's text mininghttps://conductscience.org/library/genes/1993NCBI Gene
MIR125B1406911PubTator's text mininghttps://conductscience.org/library/genes/406911NCBI Gene
MIR125B2406912PubTator's text mininghttps://conductscience.org/library/genes/406912NCBI Gene
PRKCA5578PubTator's text mininghttps://conductscience.org/library/genes/5578NCBI Gene
RNU6-6P26826PubTator's text mininghttps://conductscience.org/library/genes/26826NCBI Gene
SNORD4826801PubTator's text mininghttps://conductscience.org/library/genes/26801NCBI Gene
TENM110178PubTator's text mininghttps://conductscience.org/library/genes/10178NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33949293

GET https://conductscience.org/api/papers/v1/33949293/references?page=2